FilingPulse

LONA insider transaction filings

LeonaBio, Inc. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-10. Screen LONA transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-104PERCEPTIVE ADVISORS LLC — Director, 10% owner
EDELMAN JOSEPH — Director, 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner		Grant/award (A): 28,000 (derivative) @ $0EDGAR
2026-07-094PERCEPTIVE ADVISORS LLC — Director, 10% owner
EDELMAN JOSEPH — Director, 10% owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD — Director, 10% owner		Grant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-244Callori Fred — DirectorGrant/award (A): 2,333 (derivative) @ $0EDGAR
2026-06-244Silverman Peter B. — DirectorGrant/award (A): 2,333 (derivative) @ $0EDGAR
2026-06-244Kosacz Barbara — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-244Romano Kelly A — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-244Panzara Michael A. — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-244Holles Natalie C. — DirectorGrant/award (A): 2,333 (derivative) @ $0EDGAR
2026-06-244PICKERING GRANT — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-244JOHNSON JAMES A — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-06-244EDELMAN JOSEPH — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-05-074Callori Fred — DirectorGrant/award (A): 56,000 (derivative) @ $0EDGAR
2026-05-074Silverman Peter B. — DirectorGrant/award (A): 56,000 (derivative) @ $0EDGAR
2026-05-074Holles Natalie C. — DirectorGrant/award (A): 56,000 (derivative) @ $0EDGAR
2026-04-134Renninger Robert — CHIEF FINANCIAL OFFICERGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-04-134Worthington Mark — GENERAL COUNSEL and CCOGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-04-134CHURCH KEVIN — CHIEF SCIENTIFIC OFFICERGrant/award (A): 300,000 (derivative) @ $0EDGAR
2026-04-134San Martin Javier — CHIEF MEDICAL OFFICERGrant/award (A): 350,000 (derivative) @ $0EDGAR
2026-04-134Kosacz Barbara — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-134Romano Kelly A — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-134Panzara Michael A. — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-134Litton Mark James — PRESIDENT and CEO, DirectorGrant/award (A): 750,000 (derivative) @ $0EDGAR
2026-04-134PICKERING GRANT — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-134JOHNSON JAMES A — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-134FLUKE JOHN M JR — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-04-134EDELMAN JOSEPH — DirectorGrant/award (A): 28,000 (derivative) @ $0EDGAR
2026-03-054Renninger Robert — CHIEF FINANCIAL OFFICEROption exercise (M): 3,900 @ $0 · Sale (S): 906 @ $5.37 · Option exercise (M): 3,900 (derivative) @ $0EDGAR
2026-03-054Worthington Mark — GENERAL COUNSEL and CCOOption exercise (M): 5,726 @ $0 · Sale (S): 1,328 @ $5.37 · Option exercise (M): 5,726 (derivative) @ $0EDGAR
2026-03-054CHURCH KEVIN — CHIEF SCIENTIFIC OFFICEROption exercise (M): 5,856 @ $0 · Sale (S): 1,359 @ $5.37 · Option exercise (M): 5,856 (derivative) @ $0EDGAR
2026-03-054San Martin Javier — CHIEF MEDICAL OFFICEROption exercise (M): 7,418 @ $0 · Sale (S): 1,720 @ $5.37 · Option exercise (M): 7,418 (derivative) @ $0EDGAR
2026-03-054Litton Mark James — PRESIDENT and CEO, DirectorOption exercise (M): 22,254 @ $0 · Sale (S): 5,156 @ $5.37 · Option exercise (M): 22,254 (derivative) @ $0EDGAR

Recent 8-K events — LeonaBio, Inc.

FiledFormItems reportedSource
2026-08-148-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-238-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-318-K/A2.01 — Completion of Acquisition or Disposition of Assets
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-268-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-198-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-188-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-188-K/A1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-068-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LONA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →